Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$759.45B | 38.7x | 1.85 | US$94.45 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.8% Upside | Upgrade to Pro+ | |
Seven & i Co | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$45.31B | 34.7x | -2.93 | US$18 | 12.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seven i ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$45.31B | 34.7x | -2.93 | US$17.41 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kroger | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$43.32B | 15.6x | 0.23 | US$59.91 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
Sysco | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$39.33B | 20.6x | 2.04 | US$80.37 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.9% Upside | Upgrade to Pro+ | |
Fomento Economico Mexicano | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$32.59B | 28.6x | -0.29 | US$90.69 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.5% Upside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$31.80B | 19.9x | -2.86 | US$14.22 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$31.80B | 19.9x | -2.86 | US$4.60 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Koninklijke Ahold NV | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$31.78B | 16.8x | -1.11 | US$33.95 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Koninklijke Ahold ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$31.78B | 16.8x | -1.11 | US$34.50 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.4% Upside | Upgrade to Pro+ | |
Aeon ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$21.03B | 117.8x | US$24.45 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CP All ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$16.79B | 24.8x | 0.48 | US$20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
US Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$16.73B | 30.6x | 0.97 | US$71.99 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
Coles Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$16.28B | 22.7x | 12.41 | US$9.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Caseys | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$15.44B | 30.1x | 2.7 | US$415.77 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.8% Downside | Upgrade to Pro+ | |
Sprouts Farmers | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$15.40B | 44.1x | 1.03 | US$154.05 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13% Downside | Upgrade to Pro+ | |
Performance Food Group Co | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.96B | 32.5x | 44.78 | US$89.59 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.8% Upside | Upgrade to Pro+ | |
Jeronimo Martins SGPS SA ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$12.15B | 18x | -1.46 | US$39.09 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.7% Upside | Upgrade to Pro+ | |
Albertsons | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$11.23B | 11.3x | -0.95 | US$19.31 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.1% Upside | Upgrade to Pro+ | |
Marks and Spencer | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$10.20B | 15.7x | 0.65 | US$4.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marks & Spencer Group Plc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$10.20B | 15.7x | 0.65 | US$10.30 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.6% Upside | Upgrade to Pro+ | |
Carrefour SA PK | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.83B | 11.9x | -0.2 | US$2.93 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.6% Upside | Upgrade to Pro+ | |
Dino Polska ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.62B | 27.5x | 8.27 | US$48.81 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shoprite ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.21B | 26.6x | 4.01 | US$16.64 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kesko ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$7.94B | 17.9x | -0.9 | US$9.99 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
J Sainsbury PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$7.79B | 106.1x | -1.31 | US$13.55 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.7% Downside | Upgrade to Pro+ | |
Walgreens Boots | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$7.59B | -0.9x | 0.01 | US$8.74 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.7% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$7.30B | 68.4x | -0.63 | US$5.40 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Raia Drogasil ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$6.97B | 36.8x | 8.79 | US$4.59 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.7% Upside | Upgrade to Pro+ | |
Luckin Coffee | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$6.46B | 23.2x | -2.24 | US$23.99 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.3% Upside | Upgrade to Pro+ |